# EDGAR Filing Document

**Accession Number:** 0000811222
**File Stem:** 0001683168-25-009171
**Filing Date:** 2025-12
**Character Count:** 11252
**Document Hash:** 580cc0ff67512c92426a8802399527b8
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001683168-25-009171.hdr.sgml**: 20251215

**ACCESSION NUMBER**: 0001683168-25-009171

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20241025

**FILED AS OF DATE**: 20251215

**DATE AS OF CHANGE**: 20251215

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** THOMPSON DANIEL
- **CENTRAL INDEX KEY:** 0001342918

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-49709
- **FILM NUMBER:** 251572862

**MAIL ADDRESS:**
- **STREET 1:** 3753 HOWARD HUGHES PARKWAY
- **STREET 2:** SUITE 200
- **CITY:** LAS VEGAS
- **STATE:** NV
- **ZIP:** 89169
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Cardiff Lexington Corp
- **CENTRAL INDEX KEY:** 0000811222
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 841044583
- **STATE OF INCORPORATION:** FL
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 3753 HOWARD HUGHES PARKWAY
- **STREET 2:** SUITE 200
- **CITY:** LAS VEGAS
- **STATE:** NV
- **ZIP:** 89169
- **BUSINESS PHONE:** 844-628-2100

**MAIL ADDRESS:**
- **STREET 1:** 3753 HOWARD HUGHES PARKWAY
- **STREET 2:** SUITE 200
- **CITY:** LAS VEGAS
- **STATE:** NV
- **ZIP:** 89169

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CARDIFF INTERNATIONAL INC
- **DATE OF NAME CHANGE:** 20000211

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** UNITED AMERICAN INC
- **DATE OF NAME CHANGE:** 19910924

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CARDIFF FINANCIAL INC
- **DATE OF NAME CHANGE:** 19890510

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>THOMPSON DANIEL<br><sub>(Last) (First) (Middle)</sub><br>3753 HOWARD HUGHES PARKWAY, SUITE 200<br><sub>(Street)</sub><br>LAS VEGAS, NV 89169<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2024-10-25 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director [X] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_Chairman of the Board_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>Cardiff Lexington Corp [ CDIX ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock | 2024-10-25 |  | C<sup>(1)</sup> |  | 26124 | A | $0 | 26128 | I | Held by 2007 Thompson Family Trust |
| Common Stock | 2024-10-25 |  | C<sup>(2)</sup> |  | 10000 | A | $0 | 36128 | I | Held by 2007 Thompson Family Trust |
| Common Stock | 2025-04-24 |  | C<sup>(5)</sup> |  | 1050000 | A | $0 | 2050337 | D |  |
| Common Stock | 2025-04-24 |  | C<sup>(6)</sup> |  | 270000 | A | $0 | 2320337 | D |  |
| Common Stock | 2025-04-24 |  | C<sup>(7)</sup> |  | 154000 | A | $0 | 2474337 | D |  |
| Common Stock | 2025-11-19 |  | C<sup>(8)</sup> |  | 9192092 | A | $0 | 11666429 | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Series B Preferred Stock | <sup>(9)</sup> | 2024-10-25 |  | C<sup>(1)</sup> |  |  | 13062 | 2013-12-05 | <sup>(9)</sup> | Common Stock | 26124 | $0.00 | 0 | I | Held by 2007 Thompson Family Trust |
| Series C Preferred Stock | <sup>(10)</sup> | 2024-10-25 |  | C<sup>(2)</sup> |  |  | 1 | 2013-12-05 | <sup>(10)</sup> | Common Stock | 10000 | $0.00 | 0 | I | Held by 2007 Thompson Family Trust |
| Series I Preferred Stock | <sup>(12)</sup> | 2024-11-20 |  | J<sup>(3)</sup> |  |  | 510704 | 2018-11-21 | <sup>(12)</sup> | Common Stock | 1021408 | $0.00 | 4791796 | D |  |
| Series B Preferred Stock | <sup>(9)</sup> | 2024-11-20 |  | J<sup>(3)</sup> |  | 375000 |  | 2024-11-20 | <sup>(9)</sup> | Common Stock | 750000 | $0.00 | 375000 | D |  |
| Series C Preferred Stock | <sup>(10)</sup> | 2024-11-20 |  | J<sup>(3)</sup> |  | 24 |  | 2024-11-20 | <sup>(10)</sup> | Common Stock | 24000 | $0.00 | 24 | D |  |
| Series E Preferred Stock | <sup>(11)</sup> | 2024-11-20 |  | J<sup>(3)</sup> |  | 50000 |  | 2024-11-20 | <sup>(11)</sup> | Common Stock | 100000 | $0.00 | 50000 | D |  |
| Series I Preferred Stock | <sup>(12)</sup> | 2025-04-09 |  | J<sup>(4)</sup> |  |  | 195750 | 2018-11-21 | <sup>(12)</sup> | Common Stock | 391500 | $0.00 | 4596046 | D |  |
| Series B Preferred Stock | <sup>(9)</sup> | 2025-04-09 |  | J<sup>(4)</sup> |  | 150000 |  | 2025-04-09 | <sup>(9)</sup> | Common Stock | 300000 | $0.00 | 525000 | D |  |
| Series C Preferred Stock | <sup>(10)</sup> | 2025-04-09 |  | J<sup>(4)</sup> |  | 3 |  | 2025-04-09 | <sup>(10)</sup> | Common Stock | 30000 | $0.00 | 27 | D |  |
| Series E Preferred Stock | <sup>(11)</sup> | 2025-04-09 |  | J<sup>(4)</sup> |  | 27000 |  | 2025-04-09 | <sup>(11)</sup> | Common Stock | 54000 | $0.00 | 77000 | D |  |
| Series B Preferred Stock | <sup>(9)</sup> | 2025-04-24 |  | C<sup>(5)</sup> |  |  | 525000 | 2025-04-09 | <sup>(9)</sup> | Common Stock | 1050000 | $0.00 | 0 | D |  |
| Series C Preferred Stock | <sup>(10)</sup> | 2025-04-24 |  | C<sup>(6)</sup> |  |  | 27 | 2025-04-09 | <sup>(10)</sup> | Common Stock | 270000 | $0.00 | 0 | D |  |
| Series E Preferred Stock | <sup>(11)</sup> | 2025-04-24 |  | C<sup>(7)</sup> |  |  | 77000 | 2025-04-09 | <sup>(11)</sup> | Common Stock | 154000 | $0.00 | 0 | D |  |
| Series I Preferred Stock | <sup>(12)</sup> | 2025-11-19 |  | C<sup>(8)</sup> |  |  | 4596046 | 2018-11-21 | <sup>(12)</sup> | Common Stock | 9192092 | $0.00 | 0 | D |  |

---

### Footnotes:

(1) On October 25, 2024, the Reporting Person converted 13,062 shares of Series B Preferred Stock into 26,124 shares of Common Stock.

(2) On October 25, 2024, the Reporting Person converted 1 share of Series C Preferred Stock into 10,000 shares of Common Stock.

(3) On November 20, 2024, the Reporting Person entered into a cancellation and exchange agreement with the Issuer, pursuant to which the Reporting Person surrendered 510,704 shares of Series I Preferred Stock to the Issuer for cancellation in exchange for the issuance of 375,000 shares of Series B Preferred Stock, 24 shares of Series C Preferred Stock and 50,000 shares of Series E Preferred Stock to the Reporting Person.

(4) On April 9, 2025, the Reporting Person entered into a cancellation and exchange agreement with the Issuer, pursuant to which the Reporting Person surrendered 195,750 shares of Series I Preferred Stock to the Issuer for cancellation in exchange for the issuance of 150,000 shares of Series B Preferred Stock, 3 shares of Series C Preferred Stock and 27,000 shares of Series E Preferred Stock to the Reporting Person.

(5) On April 24, 2025, all shares of Series B Preferred Stock, including those held by the Reporting Person, were automatically converted into shares of Common Stock.

(6) On April 24, 2025, all shares of Series C Preferred Stock, including those held by the Reporting Person, were automatically converted into shares of Common Stock.

(7) On April 24, 2025, all shares of Series E Preferred Stock, including those held by the Reporting Person, were automatically converted into shares of Common Stock.

(8) On November 19, 2025, all shares of Series I Preferred Stock, including those held by the Reporting Person, were automatically converted into shares of Common Stock.

(9) Each share of Series B Preferred Stock is convertible into two (2) shares of Common Stock. The Series B Preferred Stock has no expiration date.

(10) Each share of Series C Preferred Stock is convertible into 10,000 shares of Common Stock. The Series C Preferred Stock has no expiration date.

(11) Each share of Series E Preferred Stock is convertible into two (2) shares of Common Stock. The Series E Preferred Stock has no expiration date.

(12) Each share of Series I Preferred Stock is convertible into two (2) shares of Common Stock. The Series I Preferred Stock has no expiration date.

**Signature:** /s/ Daniel R. Thompson  
**Date:** 2025-12-15

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**